Lipocine Inc banner

Lipocine Inc
F:2VT

Watchlist Manager
Lipocine Inc Logo
Lipocine Inc
F:2VT
Watchlist
Price: 3.672 EUR Market Closed
Market Cap: €19.1m

Wall St Price Targets

2VT Price Targets Summary
Lipocine Inc

Wall Street analysts forecast 2VT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2VT is 9.944 EUR with a low forecast of 9.846 EUR and a high forecast of 10.236 EUR.

Lowest Forecast
Price Target
9.846 EUR
168% Upside
Average Forecast
Price Target
9.944 EUR
171% Upside
Highest Forecast
Price Target
10.236 EUR
179% Upside
Lipocine Inc Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
112% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat
N/A
Past Growth
112% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat

The compound annual growth rate for Revenue over the next 5 years is 112%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-83%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-83%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 2VT's stock price target?
Price Target
9.944 EUR

According to Wall Street analysts, the average 1-year price target for 2VT is 9.944 EUR with a low forecast of 9.846 EUR and a high forecast of 10.236 EUR.

What is the Revenue forecast for Lipocine Inc?
Projected CAGR
112%

The compound annual growth rate for Revenue over the next 5 years is 112%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett